These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9535414)

  • 1. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
    Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
    Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
    Chen Z; Tan F; Erdös EG; Deddish PA
    Hypertension; 2005 Dec; 46(6):1368-73. PubMed ID: 16246972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of bradykinin and resensitization of its B2 receptor.
    Marcic B; Deddish PA; Jackman HL; Erdös EG
    Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B; de Vries R; Saxena PR; Danser AH
    Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
    Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
    Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
    Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the N-terminal sequence of ACE on the properties of its C-domain.
    Marcic B; Deddish PA; Jackman HL; Erdös EG; Tan F
    Hypertension; 2000 Jul; 36(1):116-21. PubMed ID: 10904022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.
    Erdös EG; Jackman HL; Brovkovych V; Tan F; Deddish PA
    J Mol Cell Cardiol; 2002 Dec; 34(12):1569-76. PubMed ID: 12505055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
    Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
    Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
    Chappell MC; Pirro NT; Sykes A; Ferrario CM
    Hypertension; 1998 Jan; 31(1 Pt 2):362-7. PubMed ID: 9453329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor.
    Deddish PA; Marcic BM; Tan F; Jackman HL; Chen Z; Erdös EG
    Hypertension; 2002 Feb; 39(2 Pt 2):619-23. PubMed ID: 11882619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
    Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT
    J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.
    Campbell DJ; Duncan AM; Kladis A
    Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
    Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
    J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling.
    Guimarães PB; Alvarenga ÉC; Siqueira PD; Paredes-Gamero EJ; Sabatini RA; Morais RL; Reis RI; Santos EL; Teixeira LG; Casarini DE; Martin RP; Shimuta SI; Carmona AK; Nakaie CR; Jasiulionis MG; Ferreira AT; Pesquero JL; Oliveira SM; Bader M; Costa-Neto CM; Pesquero JB
    Hypertension; 2011 May; 57(5):965-72. PubMed ID: 21422380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.
    Jackman HL; Massad MG; Sekosan M; Tan F; Brovkovych V; Marcic BM; Erdös EG
    Hypertension; 2002 May; 39(5):976-81. PubMed ID: 12019279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
    Tom B; Dendorfer A; Danser AH
    Int J Biochem Cell Biol; 2003 Jun; 35(6):792-801. PubMed ID: 12676166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
    Li P; Chappell MC; Ferrario CM; Brosnihan KB
    Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.